Cyclerion Therapeutics Inc (NASDAQ: CYCN) — Healthcare · Share Price, Chart & Market Data
About: Cyclerion Therapeutics, Inc., a biopharmaceutical company, develops treatments for serious diseases serious diseases with novel sGC stimulators in both the central nervous system (CNS) and the periphery. It is developing Olinciguat, an orally administered vascular soluble guanylate cyclase (sGC) stimulator, which is in Phase 2 clinical trial to treat cardiovascular diseases; and Praliciguat, a systemic sGC stimulator for the treatment of rare kidney disease. It has a license agreement with Akebia to develop, manufacture, medical affair, and commercializes Praliciguat and other related products. The company was incorporated in 2018 and is headquartered in Cambridge, Massachusetts.
Sector: Healthcare
Industry: Biotechnology
Latest price: $2.94 (-0.34%)
CYCNCyclerion Therapeutics Inc
Loading watchlist status…
Trade CYCN now
Cyclerion Therapeutics Inc share price
CYCN price activity
Last Price
Change (24hr)
USD (%)
Volume
Volume (4w avg)
Previous Close
N/A
Last Trade
Delayed
27 Apr, 10:47 am GMT+0
CYCN price performance
-2%
5D
95.349%
1M
119.403%
YTD
-20.541%
1Y
CYCN price fundamentals
N/A
Shares Issued
N/A
Dividends Per Share (DPS)
N/A
Earnings Per Share (EPS)
N/A
P/E Ratio
Price market cap
Market cap
N/A
NASDAQ rank
N/A
Sector Rank
N/A
Delayed
27 Apr, 10:47 am GMT+0
CYCN details
CYCN Market Signals